Description

The global animal health market is poised to grow by US$ 20.4 billion during 2022-2028, progressing at a CAGR of 6.5% during the forecast period, according to data and analytics company StrategyHelix.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for animal health. The global animal health market is segmented on the basis of product, animal type, route of administration, distribution channel, and region. By product, the global animal health market has been segmented into feed additives, pharmaceuticals, vaccines. Based upon animal type, the global animal health market is categorized into companion animal, farm animal. On the basis of route of administration, the global animal health market has been segmented into oral, parenteral, topical, others. By distribution channel, the global animal health market has been segmented into e-commerce, retail, veterinary hospitals & clinics, others. Geographically, the global animal health market is segmented into Asia Pacific, Europe, North America, Rest of the World (RoW).

The farm animal market is further segmented into cattle, poultry, sheep & goats, swine, and others. Furthermore, the companion animal market has been categorized into cat, dog, equine, and others. The pharmaceuticals market is further divided into analgesics, anti-infectives, anti-inflammatory, parasiticides, and others. The vaccines market is further segmented into DNA vaccines, inactivated vaccines, live attenuated vaccines, recombinant vaccines, and others.

The global animal health market is highly competitive. Key companies profiled in the report include Boehringer Ingelheim International GmbH, Ceva Sante Animale S.A., Chanelle Pharma Group Ltd., Elanco Animal Health Incorporated, Heska Corporation, Merck & Co. Inc., Nutreco N.V. (SHV Holdings NV), Vetoquinol S.A., Virbac S.A., Zoetis Inc.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the animal health market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Product: feed additives, pharmaceuticals, vaccines
Animal type: companion animal, farm animal
Route of administration: oral, parenteral, topical, others
Distribution channel: e-commerce, retail, veterinary hospitals & clinics, others
Region: Asia Pacific, Europe, North America, Rest of the World (RoW)
Years considered: this report covers the period 2018 to 2028

Key Benefits for Stakeholders

– Get a comprehensive picture of the global animal health market
– Pinpoint growth sectors and trends for investment

Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Animal health market overview
Part 3. Market breakdown by product
– Feed additives
– Pharmaceuticals
– Vaccines
Part 4. Market breakdown by animal type
– Companion animal
– Farm animal
Part 5. Market breakdown by route of administration
– Oral
– Parenteral
– Topical
– Others
Part 6. Market breakdown by distribution channel
– E-commerce
– Retail
– Veterinary hospitals & clinics
– Others
Part 7. Market breakdown by region
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)
Part 8. Key companies
– Boehringer Ingelheim International GmbH
– Ceva Sante Animale S.A.
– Chanelle Pharma Group Ltd.
– Elanco Animal Health Incorporated
– Heska Corporation
– Merck & Co., Inc.
– Nutreco N.V. (SHV Holdings NV)
– Vetoquinol S.A.
– Virbac S.A.
– Zoetis Inc.
About StrategyHelix
Disclaimer